Global and China Peripheral Intervention Drug-Eluting Devices Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Peripheral Intervention Drug-Eluting Devices industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • St Jude Medical, Inc

    • Cardinal Health

    • B Braun Melsungen AG

    • Boston Scientific Corporation

    • CR Bard, Inc

    • Abbott Laboratories

    • Medtronic plc

    • The Lubrizol Corporation

    • Biosensors International Group Ltd

    • Terumo Corporation

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Plain Old Balloon Angioplasty (POBA)

    • Percutaneous Transluminal Angioplasty (PTA)

    Application:

    • Drug-Eluting Balloons

    • Drug-Eluting Stents

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Peripheral Intervention Drug-Eluting Devices Industry Overview

      • 1.1.1 Peripheral Intervention Drug-Eluting Devices Market Scope and Market Segments

      • 1.1.2 Peripheral Intervention Drug-Eluting Devices Industry Characteristics

      • 1.1.3 Global and China Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Peripheral Intervention Drug-Eluting Devices Production Value and Growth Rate (2017-2028)

    • 1.2 Global Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Plain Old Balloon Angioplasty (POBA)

      • 1.2.2 Percutaneous Transluminal Angioplasty (PTA)

    • 1.3 Global Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Drug-Eluting Balloons

      • 1.3.2 Drug-Eluting Stents

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Peripheral Intervention Drug-Eluting Devices Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Peripheral Intervention Drug-Eluting Devices Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Peripheral Intervention Drug-Eluting Devices Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Peripheral Intervention Drug-Eluting Devices Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Peripheral Intervention Drug-Eluting Devices Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Peripheral Intervention Drug-Eluting Devices Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Peripheral Intervention Drug-Eluting Devices Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Peripheral Intervention Drug-Eluting Devices Industry Porter's Five Forces Model Analysis

      • 2.2.3 Peripheral Intervention Drug-Eluting Devices Industry PEST Analysis

    • 2.3 Peripheral Intervention Drug-Eluting Devices Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Peripheral Intervention Drug-Eluting Devices Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Peripheral Intervention Drug-Eluting Devices Industry

    Chapter 3 Global and China Peripheral Intervention Drug-Eluting Devices Market, by Manufacturer

    • 3.1 Global and China Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Peripheral Intervention Drug-Eluting Devices Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Peripheral Intervention Drug-Eluting Devices Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Peripheral Intervention Drug-Eluting Devices Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Peripheral Intervention Drug-Eluting Devices Market Top 3 Players

    Chapter 4 Global and China Peripheral Intervention Drug-Eluting Devices Market, by Type (2017-2028)

    • 4.1 Peripheral Intervention Drug-Eluting Devices Market Trend, by Type

    • 4.2 Global Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Trend, by Type (2017-2028)

    • 4.3 China Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Peripheral Intervention Drug-Eluting Devices Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Peripheral Intervention Drug-Eluting Devices Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Peripheral Intervention Drug-Eluting Devices Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Peripheral Intervention Drug-Eluting Devices Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Peripheral Intervention Drug-Eluting Devices Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Peripheral Intervention Drug-Eluting Devices Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Peripheral Intervention Drug-Eluting Devices Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Peripheral Intervention Drug-Eluting Devices Market Analysis

    • 7.1 North America Peripheral Intervention Drug-Eluting Devices Market, by Type

    • 7.2 North America Peripheral Intervention Drug-Eluting Devices Market, by Application

    • 7.3 North America Peripheral Intervention Drug-Eluting Devices Market Analysis and Forecast, by Country

      • 7.3.1 United States Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Peripheral Intervention Drug-Eluting Devices Market Analysis

    • 8.1 Europe Peripheral Intervention Drug-Eluting Devices Market, by Type

    • 8.2 Europe Peripheral Intervention Drug-Eluting Devices Market, by Application

    • 8.3 Europe Peripheral Intervention Drug-Eluting Devices Market Analysis and Forecast, by Country

      • 8.3.1 Germany Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Peripheral Intervention Drug-Eluting Devices Market Analysis

    • 9.1 APAC Peripheral Intervention Drug-Eluting Devices Market, by Type

    • 9.2 APAC Peripheral Intervention Drug-Eluting Devices Market, by Application

    • 9.3 APAC Peripheral Intervention Drug-Eluting Devices Market Analysis and Forecast, by Country

      • 9.3.1 China Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Analysis

    • 10.1 Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market, by Type

    • 10.2 Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market, by Application

    • 10.3 Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Peripheral Intervention Drug-Eluting Devices Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Peripheral Intervention Drug-Eluting Devices Company Profiles

      • 11.1 St Jude Medical, Inc

        • 11.1.1 St Jude Medical, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 St Jude Medical, Inc Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.1.3 St Jude Medical, Inc Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Cardinal Health

        • 11.2.1 Cardinal Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.2.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 B Braun Melsungen AG

        • 11.3.1 B Braun Melsungen AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.3.3 B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Boston Scientific Corporation

        • 11.4.1 Boston Scientific Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.4.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 CR Bard, Inc

        • 11.5.1 CR Bard, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 CR Bard, Inc Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.5.3 CR Bard, Inc Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Abbott Laboratories

        • 11.6.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.6.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Medtronic plc

        • 11.7.1 Medtronic plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.7.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 The Lubrizol Corporation

        • 11.8.1 The Lubrizol Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.8.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Biosensors International Group Ltd

        • 11.9.1 Biosensors International Group Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.9.3 Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Terumo Corporation

        • 11.10.1 Terumo Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Profiles, Application and Specification

        • 11.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Peripheral Intervention Drug-Eluting Devices Industry Investment Prospect and Risk Assessment

    • 12.1 Peripheral Intervention Drug-Eluting Devices Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Peripheral Intervention Drug-Eluting Devices Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Production Value and Growth Rate (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Production Value and Growth Rate (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Plain Old Balloon Angioplasty (POBA) (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Percutaneous Transluminal Angioplasty (PTA) (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Drug-Eluting Balloons (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Market Size and Growth Rate of Drug-Eluting Stents (2017-2028)

    • Figure North America Peripheral Intervention Drug-Eluting Devices Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Peripheral Intervention Drug-Eluting Devices Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Peripheral Intervention Drug-Eluting Devices Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Peripheral Intervention Drug-Eluting Devices Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Peripheral Intervention Drug-Eluting Devices Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Peripheral Intervention Drug-Eluting Devices Market Share, by Manufacturer in 2021

    • Figure Global and China Peripheral Intervention Drug-Eluting Devices Market Share, by Manufacturer in 2022

    • Table Global Peripheral Intervention Drug-Eluting Devices Sales Volume, by Type (2017-2028)

    • Table Global Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Table Global Peripheral Intervention Drug-Eluting Devices Sales Value, by Type (2017-2028)

    • Table Global Peripheral Intervention Drug-Eluting Devices Sales Value Share, by Type (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Price Trend, by Type (2017-2028)

    • Table China Peripheral Intervention Drug-Eluting Devices Sales Volume, by Type (2017-2028)

    • Table China Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Table China Peripheral Intervention Drug-Eluting Devices Sales Value, by Type (2017-2028)

    • Table China Peripheral Intervention Drug-Eluting Devices Sales Value Share, by Type (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Price Trend, by Type (2017-2028)

    • Table Global Peripheral Intervention Drug-Eluting Devices Sales Volume, by Application (2017-2028)

    • Table Global Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Table Global Peripheral Intervention Drug-Eluting Devices Sales Value, by Application (2017-2028)

    • Table Global Peripheral Intervention Drug-Eluting Devices Sales Value Share, by Application (2017-2028)

    • Figure Global Peripheral Intervention Drug-Eluting Devices Sales Value Share, by Application (2017-2028)

    • Table China Peripheral Intervention Drug-Eluting Devices Sales Volume, by Application (2017-2028)

    • Table China Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Table China Peripheral Intervention Drug-Eluting Devices Sales Value, by Application (2017-2028)

    • Table China Peripheral Intervention Drug-Eluting Devices Sales Value Share, by Application (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Sales Value Share, by Application (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    • Figure North America Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Production, Import, Consumption and Export (2017-2022)

    • Table North America Peripheral Intervention Drug-Eluting Devices Sales Volume, by Type (2017-2028)

    • Table North America Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Figure North America Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Table North America Peripheral Intervention Drug-Eluting Devices Sales Volume, by Application (2017-2028)

    • Table North America Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure North America Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure United States Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure United States Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Canada Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Table Europe Peripheral Intervention Drug-Eluting Devices Sales Volume, by Type (2017-2028)

    • Table Europe Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Figure Europe Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Table Europe Peripheral Intervention Drug-Eluting Devices Sales Volume, by Application (2017-2028)

    • Table Europe Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure Europe Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure Germany Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure UK Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure UK Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure France Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure France Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Italy Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Spain Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Poland Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Russia Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Table APAC Peripheral Intervention Drug-Eluting Devices Sales Volume, by Type (2017-2028)

    • Table APAC Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Figure APAC Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Table APAC Peripheral Intervention Drug-Eluting Devices Sales Volume, by Application (2017-2028)

    • Table APAC Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure APAC Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure China Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Japan Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure India Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure India Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Peripheral Intervention Drug-Eluting Devices Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Peripheral Intervention Drug-Eluting Devices Sales Value and Growth Rate (2017-2028)

    • Table St Jude Medical, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table St Jude Medical, Inc Product Profiles, Application and Specification

    • Table St Jude Medical, Inc Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cardinal Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cardinal Health Product Profiles, Application and Specification

    • Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table B Braun Melsungen AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table B Braun Melsungen AG Product Profiles, Application and Specification

    • Table B Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boston Scientific Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boston Scientific Corporation Product Profiles, Application and Specification

    • Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CR Bard, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CR Bard, Inc Product Profiles, Application and Specification

    • Table CR Bard, Inc Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Medtronic plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Medtronic plc Product Profiles, Application and Specification

    • Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table The Lubrizol Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table The Lubrizol Corporation Product Profiles, Application and Specification

    • Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biosensors International Group Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biosensors International Group Ltd Product Profiles, Application and Specification

    • Table Biosensors International Group Ltd Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Terumo Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Terumo Corporation Product Profiles, Application and Specification

    • Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.